Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes.
Nishimura R, Fujiki Y, Taira T, Miyaki T, Kanemitsu S, Yotsumoto D, Teraoka M, Kawano J, Gondo N, Mitsueda R, Baba S, Ohi Y, Rai Y, Sagara Y, Sagara Y. Nishimura R, et al. Among authors: teraoka m. Clin Breast Cancer. 2024 Jul;24(5):431-438. doi: 10.1016/j.clbc.2024.02.013. Epub 2024 Feb 22. Clin Breast Cancer. 2024. PMID: 38472058
ASO Author Reflections: Patients' Satisfaction After Breast Conserving Surgery Using the Suture Scaffold Technique.
Mitsueda R, Gen A, Fujiki Y, Gondo N, Sato M, Kawano J, Kuninaka K, Kanemitsu S, Teraoka M, Matsuyama Y, Baba S, Nomoto S, Sloan R, Rai Y, Sagara Y, Sagara Y. Mitsueda R, et al. Among authors: teraoka m. Ann Surg Oncol. 2022 Jun;29(6):3836-3837. doi: 10.1245/s10434-022-11513-4. Epub 2022 Mar 9. Ann Surg Oncol. 2022. PMID: 35266082 No abstract available.
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer.
Fujiki Y, Kashiwaba M, Sato M, Kawano J, Teraoka M, Kanemitsu S, Rai Y, Taira T, Sagara Y, Ohi Y, Jo U, Lee YW, Lee SB, Gong G, Shin YK, Kwon MJ, Sagara Y. Fujiki Y, et al. Among authors: teraoka m. Breast Cancer. 2024 Jan;31(1):31-41. doi: 10.1007/s12282-023-01509-7. Epub 2023 Oct 9. Breast Cancer. 2024. PMID: 37812303 Free PMC article.
Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional Study.
Mitsueda R, Gen A, Fujiki Y, Gondo N, Sato M, Kawano J, Kuninaka K, Kanemitsu S, Teraoka M, Matsuyama Y, Baba S, Nomoto S, Sloan R, Rai Y, Sagara Y, Sagara Y. Mitsueda R, et al. Among authors: teraoka m. Ann Surg Oncol. 2022 Jun;29(6):3829-3835. doi: 10.1245/s10434-022-11446-y. Epub 2022 Mar 11. Ann Surg Oncol. 2022. PMID: 35275329
Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab.
Nishimura R, Toh U, Tanaka M, Saimura M, Okumura Y, Saito T, Tanaka T, Teraoka M, Shimada K, Katayama K, Koga T, Kurashita K, Hasegawa S, Todoroki H, Kai Y, Ohi Y, Toyoshima S, Arima N, Mitsuyama S, Tamura K. Nishimura R, et al. Among authors: teraoka m. Oncology. 2017;93(1):51-61. doi: 10.1159/000468521. Epub 2017 May 6. Oncology. 2017. PMID: 28478451
101 results